Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Northrim BanCorp | NRIM | 24. dec 2024 | 78.90 | +1.02 |
Northrop Grumman | NOC | 24. dec 2024 | 471.09 | +0.83 |
NorthView Acquisition | NVAC | 24. dec 2024 | 11.71 | 0.00 |
Northwest Bancshares | NWBI | 24. dec 2024 | 13.42 | +0.75 |
Northwest Natural Holdings | NWN | 24. dec 2024 | 39.68 | +0.46 |
Northwest Pipe | NWPX | 24. dec 2024 | 50.16 | +1.54 |
NorthWestern Energy | NWE | 24. dec 2024 | 53.18 | +0.83 |
Norwegian Cruise Line | NCLH | 24. dec 2024 | 26.42 | +1.11 |
Norwood Financial | NWFL | 24. dec 2024 | 27.25 | -0.40 |
Notable Labs | NTBL | 24. dec 2024 | 0.34 | 0.00 |
Nouveau Monde Graphite | NMG | 24. dec 2024 | 1.57 | +1.95 |
NOV | NOV | 24. dec 2024 | 14.50 | +1.26 |
Nova | NVMI | 24. dec 2024 | 203.15 | +2.00 |
Nova Lifestyle | NVFY | 24. dec 2024 | 0.53 | -5.36 |
Nova Minerals | NVA | 24. dec 2024 | 12.99 | -3.06 |
Nova Vision Acquisition | NOVV | 24. dec 2024 | 37.00 | 0.00 |
Novabay Pharmaceuticals | NBY | 24. dec 2024 | 0.54 | +4.49 |
Novagold Resources | NG | 24. dec 2024 | 3.30 | +0.92 |
Novanta | NOVT | 24. dec 2024 | 155.56 | +1.13 |
Novartis ADR | NVS | 24. dec 2024 | 98.35 | -0.10 |
Novavax | NVAX | 24. dec 2024 | 8.51 | -1.50 |
Novo Nordisk ADR | NVO | 24. dec 2024 | 87.37 | -1.51 |
NovoCure | NVCR | 24. dec 2024 | 30.97 | +1.57 |
Novonix ADR | NVX | 24. dec 2024 | 1.77 | +4.12 |
NRG Energy | NRG | 24. dec 2024 | 93.03 | +0.86 |
NRx Pharmaceuticals | NRXP | 24. dec 2024 | 1.57 | +10.56 |
NSTS Bancorp | NSTS | 24. dec 2024 | 11.75 | +1.21 |
Nu Holdings | NU | 24. dec 2024 | 10.37 | +1.27 |
Nu Skin Enterprises | NUS | 24. dec 2024 | 6.66 | -1.04 |
Nuburu | BURU | 24. dec 2024 | 0.43 | +1.69 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.